[1]
Santiago, D. et al. 2021. Brand-to-Generic Substitution of Buprenorphine/Naloxone Sublingual Film in Puerto Rico: A Case Study. Puerto Rico Health Sciences Journal. 40, 4 (Nov. 2021), 192–194.